Nurofen's maker admits misleading consumers over contents of painkillers

The drug giant Reckitt Benckiser was ordered on Monday to pull some of its popular Nurofen painkiller brands off shelves in Australia after a court ruled it had made misleading claims.
The company has admitted to selling identical products that were marketed to treat specific types of pain, and for almost double the price of its standard painkiller.
The court ordered that Nurofen Back Pain, Nurofen Period Pain, Nurofen Migraine Pain and Nurofen Tension Headache be removed from retail shelves within three months.